The molecular basis of restless legs syndrome

Current Opinion in Neurobiology

Volumn 23, Issue 5, 2013, Pages 895-900

  Freeman, Amanda AH ^a   Rye, David B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; IRON;

CARDIOVASCULAR DISEASE; EMOTIONAL DISORDER; GENETIC DISORDER; GENETIC VARIABILITY; HEREDITY; HUMAN; MOTOR DYSFUNCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; SENSORY DYSFUNCTION; SLEEP DISORDER;

ANIMALS; BRAIN; HUMANS; RESTLESS LEGS SYNDROME;

EID: 84884351937     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2013.07.001     Document Type: Review

References (55)

1. Picchietti D., Allen R.P., Walters A.S., Davidson J.E., Myers A., Ferini-Strambi L. Restless legs syndrome: prevalence and impact in children and adolescents-the Peds REST study. Pediatrics 2007, 120:253-266.
2. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101-119.
3. Rye D.B., Trotti L.M. Restless legs syndrome and periodic leg movements of sleep. Neurol Clin 2012, 30:1137-1166.
4. Rye D., Trotti L.M. Restless legs syndrome and periodic leg movements of sleep. Movement Disorders 2012, 909-933. Mc-Graw-Hill. edn 3. R.L. Watts, D.G. Standaert, J.A. Obeso (Eds.).
5. Winkelman J.W. Periodic limb movements in sleep-endophenotype for restless legs syndrome?. N Engl J Med 2007, 357:703-705.
6. Trenkwalder C., Hening W.A., Walters A.S., Campbell S.S., Rahman K., Chokroverty S. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord 1999, 14:102-110.
7. Michaud M., Dumont M., Selmaoui B., Paquet J., Fantini M., Montplaisir J. Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol 2004, 55:372-380.
8. Baier P., Trenkwalder C. Circadian variation in restless legs syndrome. Sleep Med 2007, 8.
9. Hening W.A., Walters A.S., Wagner M., Rosen R., Chen V., Kim S., Shah M., Thai O. Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome. Sleep 1999, 22:901-912.
10. Duffy J.F., Lowe A.S., Silva E.J., Winkelman J.W. Periodic limb movements in sleep exhibit a circadian rhythm that is maximal in the late evening/early night. Sleep Med 2011, 12:83-88.
11. Stefansson H., Rye D.B., Hicks A., Petursson H., Ingason A., Thorgeirsson T.E., Palsson S., Sigmundsson T., Sigurdsson A.P., Eiriksdottir I., et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007, 357:639-647.
12. Winkelmann J., Schormair B., Lichtner P., Ripke S., Xiong L., Jalilzadeh S., Fulda S., Putz B., Eckstein G., Hauk S., et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007, 39:1000-1006.
13. Vilarino-Guell C., Farrer M.J., Lin S.C. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2008, 358:425-427.
14. Schormair B., Kemlink D., Roeske D., Eckstein G., Xiong L., Lichtner P., Ripke S., Trenkwalder C., Zimprich A., Stiasny-Kolster K., et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 2008, 40:946-948.
15. Winkelmann J., Czamara D., Schormair B., Knauf F., Schulte E.C., Trenkwalder C., Dauvilliers Y., Polo O., Hogl B., Berger K., et al. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 2011, 7:e1002171.
16. Mignot E. A step forward for restless legs syndrome. Nat Genet 2007, 39:938-939.
17. Xiong L., Catoire H., Dion P., Gaspar C., Lafreniere R.G., Girard S.L., Levchenko A., Riviere J.B., Fiori L., St-Onge J., et al. MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum Mol Genet 2009, 18:1065-1074.
18. Vilarino-Guell C., Chai H., Keeling B.H., Young J.E., Rajput A., Lynch T., Aasly J.O., Uitti R.J., Wszolek Z.K., Farrer M.J., et al. MEIS1 p.R272H in familial restless legs syndrome. Neurology 2009, 73:243-245.
19. Schulte E.C., Knauf F., Kemlink D., Schormair B., Lichtner P., Gieger C., Meitinger T., Winkelmann J. Variant screening of the coding regions of MEIS1 in patients with restless legs syndrome. Neurology 2011, 76:1106-1108.
20. Catoire H., Dion P.A., Xiong L., Amari M., Gaudet R., Girard S.L., Noreau A., Gaspar C., Turecki G., Montplaisir J.Y., et al. Restless legs syndrome-associated MEIS1 risk variant influences iron homeostasis. Ann Neurol 2011, 70:170-175.
21. Freeman A., Pranski E., Miller R.D., Radmard S., Bernhard D., Jinnah H.A., Betarbet R., Rye D.B., Sanyal S. Sleep fragmentation and motor restlessness in a Drosophila model of restless legs syndrome. Curr Biol 2012, 22:1142-1148.
22. DeAndrade M.P., Johnson R.L., Unger E.L., Zhang L., van Groen T., Gamble K.L., Li Y. Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice. Hum Mol Genet 2012, 21:3984-3992.
23. Oexle K., Schormair B., Ried J.S., Czamara D., Heim K., Frauscher B., Hogl B., Trenkwalder C., Martin Fiedler G., Thiery J., et al. Dilution of candidates: the case of iron-related genes in restless legs syndrome. Eur J Hum Genet 2013, 21:410-414.
24. Schormair B., Plag J., Kaffe M., Gross N., Czamara D., Samtleben W., Lichtner P., Strohle A., Stefanidis I., Vainas A., et al. MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease. J Med Genet 2011, 48:462-466.
25. Vavrova J., Kemlink D., Sonka K., Havrdova E., Horakova D., Pardini B., Muller-Myhsok B., Winkelmann J. Restless legs syndrome in Czech patients with multiple sclerosis: an epidemiological and genetic study. Sleep Med 2012, 13:848-851.
26. Perez-Torrado R., Yamada D., Defossez P. Born to bind: the BTB protein-protein interaction domain. Bioessays Rev 2006, 28:1194-1202.
27. Bilic I., Ellmeier W. The role of BTB domain-containing zinc finger proteins in T cell development and function. Immunol Lett 2007, 108:1-9.
28. Stogios P., Downs G., Jauhal J., Nandra S., Privé G. Sequence and structural analysis of BTB domain proteins. Genome Biol 2005, 6:R82.
29. Stogios P., Privé G. The BACK domain in BTB-kelch proteins. Trends Biochem Sci 2004, 29:634-637.
30. Adams J., Kelso R., Cooley L. The kelch repeat superfamily of proteins: propellers of cell function. Trends Cell Biol 2000, 10:17-24.
31. Hashimoto Y., Muramatsu K., Kunii M., Yoshimura S., Yamada M., Sato T., Ishida Y., Harada R., Harada A. Uncovering genes required for neuronal morphology by morphology-based gene trap screening with a revertible retrovirus vector. FASEB J 2012, 26:4662-4674.
32. Stavropoulos N., Young M.W. Insomniac and Cullin-3 regulate sleep and wakefulness in Drosophila. Neuron 2011, 72:964-976.
33. Grima B., Dognon A., Lamouroux A., Chelot E., Rouyer F. CULLIN-3 controls TIMELESS oscillations in the Drosophila circadian clock. PLoS Biol 2012, 10:e1001367.
34. Pfeiffenberger C., Allada R. Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila. PLoS Genet 2012, 8:e1003003.
35. Jiang J., Struhl G. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 1998, 391:493-496.
36. Ou C.Y., Lin Y.F., Chen Y.J., Chien C.T. Distinct protein degradation mechanisms mediated by Cul1 and Cul3 controlling Ci stability in Drosophila eye development. Genes Dev 2002, 16:2403-2414.
37. Zhang Q., Zhang L., Wang B., Ou C.Y., Chien C.T., Jiang J. A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor. Dev Cell 2006, 10:719-729.
38. Zhang E.E., Liu A.C., Hirota T., Miraglia L.J., Welch G., Pongsawakul P.Y., Liu X., Atwood A., Huss J.W., Janes J., et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 2009, 139:199-210.
39. Casares F., Mann R.S. Control of antennal versus leg development in Drosophila. Nature 1998, 392:723-726.
40. Kurant E., Pai C.Y., Sharf R., Halachmi N., Sun Y.H., Salzberg A. Dorsotonals/homothorax, the Drosophila homologue of meis1, interacts with extradenticle in patterning of the embryonic PNS. Development 1998, 125:1037-1048.
41. Maeda R., Mood K., Jones T.L., Aruga J., Buchberg A.M., Daar I.O. Xmeis1, a protooncogene involved in specifying neural crest cell fate in Xenopus embryos. Oncogene 2001, 20:1329-1342.
42. Argiropoulos B., Yung E., Humphries R.K. Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. Genes Dev 2007, 21:2845-2849.
43. Azcoitia V., Aracil M., Martinez A.C., Torres M. The homeodomain protein Meis1 is essential for definitive hematopoiesis and vascular patterning in the mouse embryo. Dev Biol 2005, 280:307-320.
44. Minehata K., Kawahara A., Suzuki T. meis1 regulates the development of endothelial cells in zebrafish. Biochem Biophys Res Commun 2008, 374:647-652.
45. Davidson S., Miller K.A., Dowell A., Gildea A., Mackenzie A. A remote and highly conserved enhancer supports amygdala specific expression of the gene encoding the anxiogenic neuropeptide substance-P. Mol Psychiatry 2006, 11:323.
46. Uetani N., Chagnon M.J., Kennedy T.E., Iwakura Y., Tremblay M.L. Mammalian motoneuron axon targeting requires receptor protein tyrosine phosphatases sigma and delta. J Neurosci 2006, 26:5872-5880.
47. Naciff J.M., Overmann G.J., Torontali S.M., Carr G.J., Tiesman J.P., Richardson B.D., Daston G.P. Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol Sci 2003, 72:314-330.
48. Dinev D., Jordan B.W., Neufeld B., Lee J.D., Lindemann D., Rapp U.R., Ludwig S. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep 2001, 2:829-834.
49. Cavanaugh J.E., Jaumotte J.D., Lakoski J.M., Zigmond M.J. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. J Neurosci Res 2006, 84:1367-1375.
50. Mizuhara E., Nakatani T., Minaki Y., Sakamoto Y., Ono Y. Corl1, a novel neuronal lineage-specific transcriptional corepressor for the homeodomain transcription factor Lbx1. J Biol Chem 2005, 280:3645-3655.
51. Arndt S., Poser I., Moser M., Bosserhoff A.K. Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling. Mol Cell Neurosci 2007, 34:603-611.
52. Yuan S.H., Qiu Z., Ghosh A. TOX3 regulates calcium-dependent transcription in neurons. Proc Natl Acad Sci USA 2009, 106:2909-2914.
53. Dittmer S., Kovacs Z., Yuan S.H., Siszler G., Kogl M., Summer H., Geerts A., Golz S., Shioda T., Methner A. TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex. J Cell Sci 2011, 124:252-260.
54. Cowper-Sal lari R., Zhang X., Wright J.B., Bailey S.D., Cole M.D., Eeckhoute J., Moore J.H., Lupien M. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat Genet 2012, 44:1191-1198.
55. Trynka G., Sandor C., Han B., Xu H., Stranger B.E., Liu X.S., Raychaudhuri S. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat Genet 2013, 45:124-130.